These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14717108)

  • 21. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
    AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generic stavudine approved.
    AIDS Patient Care STDS; 2009 May; 23(5):396-7. PubMed ID: 19422067
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
    AIDS Alert; 2003 Jan; 18(1):10-1. PubMed ID: 12541998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abacavir's trials and tribulations.
    Gilden D
    GMHC Treat Issues; 1998 Nov; 12(11):1-3. PubMed ID: 11365905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory considerations for determining postmarketing study commitments.
    Meyer RJ
    Clin Pharmacol Ther; 2007 Aug; 82(2):228-30. PubMed ID: 17538552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HIV therapy update.
    Proj Inf Perspect; 2002 Mar; (34):4-6. PubMed ID: 12038301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV drugs. FDA new drug approval rate lowest in 10 years.
    AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17323437
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA notifications. Generic emtricitabine is approved by the FDA.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19222147
    [No Abstract]   [Full Text] [Related]  

  • 30. Generic Truvada approved.
    AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA notifications. FDA approved 3 generic formulations of stavudine.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On approval.
    Huff B
    GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
    [No Abstract]   [Full Text] [Related]  

  • 34. Adefovir rejected.
    Res Initiat Treat Action; 1999 Dec; 5(5):23. PubMed ID: 11366890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of the drug approval process.
    Martinez LJ
    Res Initiat Treat Action; 2002; 8(1):11-7. PubMed ID: 12489521
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA notifications. Generic lamivudine tentatively approved.
    AIDS Alert; 2008 Mar; 23(3):33. PubMed ID: 18661640
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA notifications. Accelerated approval for raltegravir tablets.
    AIDS Alert; 2007 Dec; 22(12):143-4. PubMed ID: 18411485
    [No Abstract]   [Full Text] [Related]  

  • 38. IL-2 for HIV: the long march toward FDA approval. Food and Drug Administration.
    Sterritt C
    GMHC Treat Issues; 1997 Sep; 11(9):1-3. PubMed ID: 11364749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A look ahead at this year's drug approvals.
    Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA meeting on approving immune therapies: background and comment.
    James JS
    AIDS Treat News; 2000 Oct; (353):3-7. PubMed ID: 12173555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.